The increase in the P2X7 receptor in the plasma of COVID-19 patients was higher in those with diabetes and dyslipidaemia, which in turn associates the P2X7 receptor with metabolic diseases (38, 39). The gene discussed is P2RX7; the disease is COVID-19.